We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Shah- Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma
Jatin Shah, MD
University of Texas
Houston, TX
12.03.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles